|
|
| Line 1: |
Line 1: |
| [[Image:1mzi.jpg|left|200px]] | | {{Seed}} |
| | [[Image:1mzi.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_1mzi| PDB=1mzi | SCENE= }} | | {{STRUCTURE_1mzi| PDB=1mzi | SCENE= }} |
|
| |
|
| '''Solution ensemble structures of HIV-1 gp41 2F5 mAb epitope'''
| | ===Solution ensemble structures of HIV-1 gp41 2F5 mAb epitope=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Inhibition of human immunodeficiency virus (HIV) fusion with the host cell has emerged as a viable therapeutic strategy, and rational design of inhibitors and vaccines, interfering with this process, is a prime target for antiviral research. To advance our knowledge of the structural biology of HIV fusion, we have studied the membrane-proximal region of the fusogenic envelope subunit gp41, which includes the epitope ELDKWA of the broadly neutralizing human antibody 2F5. The structural evidence available for this region is contradictory, with some studies suggesting an overall helical conformation, while the X-ray structure of the ELDKWAS peptide bound to the antibody shows it folded in a type I beta turn. We used a two-step strategy: Firstly, by a competition binding assay, we identified the proper boundaries of the domain recognized by 2F5, which we found considerably larger than the ELDKWAS hexapeptide. Secondly, we studied the structure of the resulting 13 amino acid residue peptide by collecting NMR data and analyzing them by our previously developed statistical method (NAMFIS). Our study revealed that the increase in binding affinity goes in parallel with stabilization of specific local and global conformational propensities, absent from the shorter epitope. When compounded with the available biological evidence, our structural analysis allows us to propose a specific role for the membrane-proximal region during HIV fusion, in terms of a conformational transition between the turn and the helical structure. At the same time, our hypothesis offers a structural explanation for the mechanism of neutralization of mAb 2F5.
| | The line below this paragraph, {{ABSTRACT_PUBMED_12860131}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 12860131 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_12860131}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| 1MZI is a [[Single protein]] structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MZI OCA]. | | 1MZI is a [[Single protein]] structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MZI OCA]. |
|
| |
|
| ==Reference== | | ==Reference== |
| Line 34: |
Line 38: |
| [[Category: Nmr]] | | [[Category: Nmr]] |
| [[Category: Statistic]] | | [[Category: Statistic]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 01:54:01 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 21:08:56 2008'' |